首页> 外文期刊>Clinical Interventions in Aging >Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice
【24h】

Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice

机译:草药配方B401的口服治疗可减轻R6 / 2小鼠大脑中的氧化应激和细胞凋亡,从而防止衰老相关的神经变性

获取原文
           

摘要

Background: Neurodegeneration is characterized by progressive neurological deficits due to selective neuronal loss in the nervous system. Huntington’s disease (HD) is an incurable neurodegenerative disorder. Neurodegeneration in HD patients shows aging-dependent pattern. Our previous study has suggested that a herbal formula B401 may have neuroprotective effects in the brains of R6/2 mice. Objective: To clarify possible mechanisms for neurodegeneration, which improves the understanding the aging process. This study focuses on clarifying neurodegenerative mechanisms and searching potential therapeutic targets in HD patients. Methods: The oxidative stress and apoptosis were compared in the brain tissue between R6/2 HD mice with and without oral B401 treatment. Expressions of proteins for oxidative stress and apoptosis in the brain tissue of R6/2 HD mice were examined by using immunostaining and Western blotting techniques. Results: R6/2 HD mice with oral B401 treatment significantly reduced reactive oxygen species levels in the blood, but markedly increased expressions of superoxide dismutase 2 in the brain tissue. Furthermore, R6/2 HD mice with oral B401 treatment significantly increased expressions of B-cell lymphoma 2 (Bcl-2), but significantly reduced expressions of Bcl-2-associated X protein (Bax), calpain, and caspase-3 in the brain tissue. Conclusion: Our findings provide evidence that the herbal formula B401 can remedy for aging-dependent neurodegeneration of R6/2 mice via suppressing oxidative stress and apoptosis in the brain. We suggest that the herbal formula B401 can be developed as a potential health supplement for ameliorating aging-dependent neurodegeneration.
机译:背景:神经退行性变的特征是由于神经系统中选择性神经元丢失而导致进行性神经功能缺损。亨廷顿舞蹈病(HD)是无法治愈的神经退行性疾病。 HD患者的神经变性表现出衰老依赖性模式。我们以前的研究表明,草药配方B401可能对R6 / 2小鼠的大脑具有神经保护作用。目的:阐明神经退行性变的可能机制,以增进对衰老过程的理解。这项研究的重点是阐明神经退行性机制和寻找HD患者的潜在治疗靶点。方法:比较口服和不口服B401治疗的R6 / 2 HD小鼠的脑组织氧化应激和凋亡情况。 R6 / 2 HD小鼠的脑组织中氧化应激和凋亡蛋白的表达通过免疫染色和蛋白质印迹技术进行了检测。结果:口服B401治疗的R6 / 2 HD小鼠显着降低了血液中的活性氧水平,但脑组织中超氧化物歧化酶2的表达明显增加。此外,口服B401治疗的R6 / 2 HD小鼠显着增加B细胞淋巴瘤2(Bcl-2)的表达,但显着降低Bcl-2相关X蛋白(Bax),钙蛋白酶和caspase-3的表达。脑组织。结论:我们的发现提供了证据,表明草药配方B401可通过抑制脑中的氧化应激和凋亡来治疗R6 / 2小鼠的衰老依赖性神经退行性变。我们建议草药配方B401可作为改善衰老依赖性神经退行性变的潜在健康补品。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号